354 results
P
Hepatocellular carcinomas (HCCs), non-HCC malignancies
I/C
Contrast-enhanced ultrasound (CEUS) Liver Imaging Reporting and Data System category M (LR-M), CEUS LR-M category, Non-HCC malignancies
O
Proportion of CEUS LR-M in HCC and non-HCC malignancies, Frequency of individual CEUS LR-M imaging features
P
patients with de novo IAs
I/C
systematic review and meta-analysis of existing de novo IA cohorts, initial IAs in the middle cerebral artery
O
de novo IAs
P
patients with liver lesions
I/C
LI-RADS algorithm, original studies reporting probability of LR-M for HCC and non-HCC malignancy on MRI
O
pooled percentages of HCC and non-HCC malignancy for LR-M, sources of heterogeneity between reported results
P
pediatric patients
I/C
canal wall-up (CWU) versus canal wall-down (CWD), recurrence and residual disease
O
hearing outcomes
P
idosos
I/C
prevenção de quedas, não-prevenção
O
prevenção de quedas
P
mycotoxins, yeast cell wall extract
I/C
mycotoxins, yeast cell wall extract
O
P
patients with renal cell carcinoma (RCC)
I/C
non-invasive imaging preoperatively, radiographic vascular size parameters
O
IVC wall invasion
P
growing pigs
I/C
mycotoxin challenge, yeast cell wall extract, no mycotoxin challenge, no yeast cell wall extract
O
performance
P
NAFLD, elderly, pre-LT type II diabetes mellitus
I/C
de novo PTMS, other liver diseases
O
cardiovascular disease events
P
broilers
I/C
mycotoxins, yeast cell wall extract, control, with inclusion of yeast cell wall extract
O
body weight gain, feed intake, feed conversion ratio, mortality, carbon footprint
